BPS3011 S1 2026 PA Assessment 3 | Progress test 1: Alzheimer's disease & Schizophrenia

A novel drug has been developed that targets a newly identified glutamate receptor subtype thought to be involved in schizophrenia. In preclinical studies, the drug improves behaviour in animal models...